Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists

Stem Cells and Development

Volumn 20, Issue 4, 2011, Pages 695-708

  Tomic, Sergej ^a   Djokic, Jelena ^a   Vasilijic, Sasa ^a   Vucevic, Dragana ^a   Todorovic, Vera ^b,c   Supic, Gordana ^a   Colic, Miodrag ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c University of Business Economy   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 6; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA;

ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENTAL FOLLICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OSTEOBLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOOTH; TOOTH PULP;

ADIPOCYTES; ANIMALS; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; CHONDROCYTES; COCULTURE TECHNIQUES; DENTAL PULP; DENTAL SAC; HUMANS; IMMUNOMODULATION; IMMUNOSUPPRESSION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; OSTEOCYTES; PHENOTYPE; POLY I-C; TOLL-LIKE RECEPTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS; YOUNG ADULT;

EID: 79953680762     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2010.0145     Document Type: Article

References (58)

1. Kolf CM, E Cho and RS Tuan. (2007). Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204-213.
2. Bianco P, M Riminucci, S Gronthos and PG Robey. (2001). Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180-192. (Pubitemid 32524539)
3. Caplan AI. (1991). Mesenchymal stem cells. J Orthop Res 9:641-650.
4. Jones EA, SE Kinsey, A English, RA Jones, L Straszynski, DM Meredith, AF Markham, A Jack, P Emery and D McGonagle. (2002). Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 46:3349-3360. (Pubitemid 35453547)
5. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147. (Pubitemid 29282067)
6. Gronthos S, M Mankani, J Brahim, PG Robey and S Shi. (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 97:13625-13630.
7. Miura M, S Gronthos, M Zhao, B Lu, LW Fisher, PG Robey and S Shi. (2003). SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A 100:5807-5812. (Pubitemid 36576889)
8. Seo BM, M Miura, S Gronthos, PM Bartold, S Batouli, J Brahim, M Young, PG Robey, CY Wang and S Shi. (2004). Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364:149-155. (Pubitemid 38891686)
9. Sonoyama W, Y Liu, T Yamaza, RS Tuan, S Wang, S Shi and GT Huang. (2008). Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod 34:166-171.
10. Morsczeck C, W Gotz, J Schierholz, F Zeilhofer, U Kuhn, C Mohl, C Sippel and KH Hoffmann. (2005). Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biol 24:155-165. (Pubitemid 40703914)
11. Huang GT, S Gronthos and S Shi. (2009). Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res 88:792-806.
12. Uccelli A, L Moretta and V Pistoia. (2006). Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36:2566-2573. (Pubitemid 44608440)
13. Le Blanc K, F Frassoni, L Ball, F Locatelli, H Roelofs, I Lewis, E Lanino, B Sundberg, ME Bernardo, M Remberger, G Dini, RM Egeler, A Bacigalupo, W Fibbe and O Ringden. (2008). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579-1586. (Pubitemid 351626841)
14. Ryan JM, F Barry, JM Murphy and BP Mahon. (2007). Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149:353-363. (Pubitemid 47063057)
15. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843. (Pubitemid 34534559)
16. Sato K, K Ozaki, I Oh, A Meguro, K Hatanaka, T Nagai, K Muroi and K Ozawa. (2007). Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109:228-234. (Pubitemid 46053063)
17. Aggarwal S and MF Pittenger. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822. (Pubitemid 40223708)
18. Selmani Z, A Naji, E Gaiffe, L Obert, P Tiberghien, N Rouas- Freiss, ED Carosella and F Deschaseaux. (2009). HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation 87:S62-S66.
19. Meisel R, A Zibert, M Laryea, U Gobel, W Daubener and D Dilloo. (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenasemediated tryptophan degradation. Blood 103:4619-4621. (Pubitemid 38745993)
20. Iwasaki A and R Medzhitov. (2004). Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-995. (Pubitemid 41057715)
21. Marshak-Rothstein A. (2006). Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6:823-835. (Pubitemid 44631651)
22. Becker CE and LA O'Neill. (2007). Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Semin Immunopathol 29:239-248. (Pubitemid 47416219)
23. Pevsner-Fischer M, V Morad, M Cohen-Sfady, L Rousso- Noori, A Zanin-Zhorov, S Cohen, IR Cohen and D Zipori. (2007). Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109:1422-1432. (Pubitemid 46239573)
24. Hwa Cho H, YC Bae and JS Jung. (2006). Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 24:2744-2752.
25. Tomchuck SL, KJ Zwezdaryk, SB Coffelt, RS Waterman, ES Danka and AB Scandurro. (2008). Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26:99-107.
26. Ohashi K, V Burkart, S Flohe and H Kolb. (2000). Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164: 558-561. (Pubitemid 30043672)
27. Cohen-Sfady M, G Nussbaum, M Pevsner-Fischer, F Mor, P Carmi, A Zanin-Zhorov, O Lider and IR Cohen. (2005). Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol 175:3594-3602. (Pubitemid 41292018)
28. Okamura Y, M Watari, ES Jerud, DW Young, ST Ishizaka, J Rose, JC Chow and JF Strauss, III. (2001). The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276:10229-10233.
29. Liotta F, R Angeli, L Cosmi, L Fili, C Manuelli, F Frosali, B Mazzinghi, L Maggi, A Pasini, V Lisi, V Santarlasci, L Consoloni, ML Angelotti, P Romagnani, P Parronchi, M Krampera, E Maggi, S Romagnani and F Annunziato. (2008). Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 26:279-289.
30. Opitz CA, UM Litzenburger, C Lutz, TV Lanz, I Tritschler, A Koppel, E Tolosa, M Hoberg, J Anderl, WK Aicher, M Weller, W Wick and M Platten. (2009). Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3- dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells 27:909-919.
31. Waterman RS, SL Tomchuck, SL Henkle and AM Betancourt. (2010). A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One 5:e10088.
32. Haddouti E-M, M Skroch, N Zippel, C Muller, B Birova, A Pansky, C Kleinfeld, M Winter and E Tobiasch. (2009). Human dental follicle precursor cells of wisdom teeth: isolation and differentiation towards osteoblasts for implants with and without scaffolds. Materialwissenschaft und Werkstofftechnik 40:732-737.
33. Horwitz EM, PL Gordon, WK Koo, JC Marx, MD Neel, RY McNall, L Muul and T Hofmann. (2002). Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A 99:8932-8937. (Pubitemid 34693661)
34. Pochampally R. (2008). Colony forming unit assays for MSCs. Methods Mol Biol 449:83-91.
35. Stevens A, T Zuliani, C Olejnik, H LeRoy, H Obriot, J Kerr- Conte, P Formstecher, Y Bailliez and RR Polakowska. (2008). Human dental pulp stem cells differentiate into neural crestderived melanocytes and have label-retaining and sphereforming abilities. Stem Cells Dev 17:1175-1184.
36. Schrijver IA, M-J Melief, Mv Meurs, AR Companjen and JD Laman. (2000). Pararosaniline fixation for detection of costimulatory molecules, cytokines, and specific antibody. J Histochem Cytochem 48:95-103. (Pubitemid 30053570)
37. Nauta AJ and WE Fibbe. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506. (Pubitemid 350159613)
38. Romieu-Mourez R, M Francois, MN Boivin, M Bouchentouf, DE Spaner and J Galipeau. (2009). Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol 182:7963-7973.
39. Gonzalez-Rey E, P Anderson, MA Gonzalez, L Rico, D Buscher and M Delgado. (2009). Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58:929-939.
40. Lindroos B, K Maenpaa, T Ylikomi, H Oja, R Suuronen and S Miettinen. (2008). Characterisation of human dental stem cells and buccal mucosa fibroblasts. Biochem Biophys Res Commun 368:329-335.
41. Luan X, Y Ito, S Dangaria and TG Diekwisch. (2006). Dental follicle progenitor cell heterogeneity in the developing mouse periodontium. Stem Cells Dev 15:595-608. (Pubitemid 44701178)
42. Battula VL, S Treml, PM Bareiss, F Gieseke, H Roelofs, P de Zwart, I Muller, B Schewe, T Skutella, WE Fibbe, L Kanz and HJ Buhring. (2009). Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 94:173-184.
43. Grinnemo KH, A Mansson, G Dellgren, D Klingberg, E Wardell, V Drvota, C Tammik, J Holgersson, O Ringden, C Sylven and K Le Blanc. (2004). Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infracted rat myocardium. J Thorac Cardiovasc Surg 127:1293-1300. (Pubitemid 38560590)
44. Niemeyer P, J Vohrer, H Schmal, P Kasten, J Fellenberg, NP Suedkamp and AT Mehlhorn. (2008). Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice. Cytotherapy 10:784-795.
45. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
46. Quirici N, D Soligo, P Bossolasco, F Servida, C Lumini and GL Deliliers. (2002). Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30:783-791. (Pubitemid 34835685)
47. Soncini M, E Vertua, L Gibelli, F Zorzi, M Denegri, A Albertini, GS Wengler and O Parolini. (2007). Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 1:296-305.
48. Dontu G, KW Jackson, E McNicholas, MJ Kawamura, WM Abdallah and MS Wicha. (2004). Role of Notch signaling in cell-fate determination of human mammary stem=progenitor cells. Breast Cancer Res 6:R605-R615.
49. Shindo K, N Kawashima, K Sakamoto, A Yamaguchi, A Umezawa, M Takagi, K Katsube and H Suda. (2003). Osteogenic differentiation of the mesenchymal progenitor cells, Kusa is suppressed by Notch signaling. Exp Cell Res 290: 370-380. (Pubitemid 37272179)
50. Zhang Q, S Shi, Y Liu, J Uyanne, Y Shi, S Shi and AD Le. (2009). Mesenchymal stem cells derived from human gingival are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 183:7787-7798.
51. Wada N, D Menicanin, S Shi, PM Bartold and S Gronthos. (2009). Immunomodulatory properties of human periodontal ligament stem cells. J Cell Physiol 219:667-676.
52. Pierdomenico L, L Bonsi, M Calvitti, D Rondelli, M Arpinati, G Chirumbolo, E Becchetti, C Marchionni, F Alviano, V Fossati, N Staffolani, M Franchina, A Grossi and GP Bagnara. (2005). Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation 80:836-842. (Pubitemid 41443768)
53. Fang L, C Lange, M Engel, AR Zander and B Fehse. (2006). Sensitive balance of suppressing and activating effects of mesenchymal stem cells on T-cell proliferation. Transplantation 82:1370-1373. (Pubitemid 44832920)
54. Bocelli-Tyndall C, L Bracci, S Schaeren, C Feder-Mengus, A Barbero, A Tyndall and GC Spagnoli. (2009). Human bone marrow mesenchymal stem cells and chondrocytes promote and=or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15. Ann Rheum Dis 68:1352-1359.
55. Eisenbarth SC, DA Piggott, JW Huleatt, I Visintin, CA Herrick and K Bottomly. (2002). Lipopolysaccharideenhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196:1645-1651. (Pubitemid 36026476)
56. Togbe D, S Schnyder-Candrian, B Schnyder, I Couillin, I Maillet, F Bihl, D Malo, B Ryffel and VF Quesniaux. (2006). TLR4 gene dosage contributes to endotoxin-induced acute respiratory inflammation. J Leukoc Biol 80:451-457. (Pubitemid 44835777)
57. Akira S, S Uematsu and O Takeuchi. (2006). Pathogen recognition and innate immunity. Cell 124:783-801. (Pubitemid 43261452)
58. McGeachy MJ, KS Bak-Jensen, Y Chen, CM Tato, W Blumenschein, T McClanahan and DJ Cua. (2007). TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8:1390-1397. (Pubitemid 350138974)